US: Pfizer "nearing" sale of infant-nutrition business
Pfizer "nearing" baby food sale
The US pharmaceutical company has previously confirmed to just-food that it is "considering strategic options" for the business, including a "sale, spin-off or other transaction".
According to a report in the Wall Street Journal, Pfizer has stuck an agreement to sell the unit to Nestle for US$9bn. Meanwhile, other reports have suggested that Nestle and Danone have both submitted competing bids, valuing the business at around $10bn.
Pfizer is expected to announce a sale of the unit next week.
Last week brought further evidence of the difficulties facing food manufacturers as they look to grow their businesses in the developed markets of the US and Europe....
just-food last week brought live coverage from the GMA/FMI Sustainability Summit in Washington DC where presentations were given from members of the Environmental Defense Fund, the Rainforest Alliance...
- Rabobank's early view on Brexit impact on food
- How local model protects Nestle - interview
- Brexit sparks uncertainty for UK food - comment
- Quorn Foods confident in prospects - interview
- Kellogg uses Kashi to finally join party - comment
- Brexit – Live reaction from food industry
- Nestle names new CEO
- Brexit – UK farmers warn of food price spike
- Brexit – US confirms commitment to TTIP with EU
- Brexit – How France's food market will be hit
- Frozen Bakery Products Market by Type, Distribution Channel, & by Region - Global Trends & Forecast to 2020
- Top Trends in Snacks, Confectionery, and Desserts; Exploring consumer and innovation trends in key categories
- Singapore Food and Drink Report Q3 2016
- Fast Food in India
- Country Analysis Report: Saudi Arabia, In-depth PESTLE Insights